Related references
Note: Only part of the references are listed.Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation
Claudio Ronco et al.
BLOOD PURIFICATION (2021)
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Viviane C. Veiga et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19
Sarita Choudhary et al.
ANNALS OF LABORATORY MEDICINE (2021)
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
Francois-Xavier Lescure et al.
LANCET RESPIRATORY MEDICINE (2021)
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
Lin Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Bryan E. Jones et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19
Peter Chen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding
Nadine Peart Akindele et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Evolution patterns of SARS-CoV-2: Snapshot on its genome variants
Marta Giovanetti et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19
Srikanth Umakanthan et al.
AIMS PUBLIC HEALTH (2021)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
Matthew Hackbart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jin Liu et al.
EBIOMEDICINE (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Clinical and pathological investigation of patients with severe COVID-19
Shaohua Li et al.
JCI INSIGHT (2020)
Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ger Rijkers et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
Lymphopenia during the COVID-19 infection: What it shows and what can be learned
Soheil Tavakolpour et al.
IMMUNOLOGY LETTERS (2020)
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology
Flavio Protasio Veras et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Serological follow-up of SARS-CoV-2 asymptomatic subjects
Gregorio Paolo Milani et al.
SCIENTIFIC REPORTS (2020)
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
Katya Uzunova et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Stimulation of Innate Immunity by Host and Viral RNAs
Felix Streicher et al.
TRENDS IN IMMUNOLOGY (2019)
Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
Xufang Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Type I interferons as Regulators of Lung inflammation
Spyridon Makris et al.
FRONTIERS IN IMMUNOLOGY (2017)
Regulation of antiviral T cell responses by type I interferons
Josh Crouse et al.
NATURE REVIEWS IMMUNOLOGY (2015)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3•TANK•TBK1/IKKε Complex
Kam-Leung Siu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2009)
Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3
M Spiegel et al.
JOURNAL OF VIROLOGY (2005)
Share Paper
